Showing 1 - 8 results of 8 for search 'Zhiwei Cui', query time: 0.10s Refine Results
  1. 1
    A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

    A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases by Qian Liu, Zhiwei Cui, Chao Deng, Chao Yang, Tao Shi

    Published 2024
    Loading…
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression

    Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression by Rumeng Pan, Rongli Wang, Feiyan Cheng, Lihui Wang, Zhiwei Cui, Jing She, Xinyuan Yang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Paucatalinone A from Paulownia Catalpifolia Gong Tong Elicits mitochondrial-mediated cancer cell death to combat osteosarcoma

    Paucatalinone A from Paulownia Catalpifolia Gong Tong Elicits mitochondrial-mediated cancer cell death to combat osteosarcoma by Ganyu Wang, Zhiwei Cui, Jinqiu Tian, Xinyuan Li, Wenzhao Tang, Weiqiang Jing, Aiwu Li, Yuankai Zhang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database

    A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database by Fan Zou, Chengyu Zhu, Siyu Lou, Zhiwei Cui, Dan Wang, Yingyong Ou, Li Wang, Junyou Chen, Yuanbo Lan

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups

    Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups by Yingyong Ou, Zhiwei Cui, Siyu Lou, Chengyu Zhu, Junyou Chen, Linmei Zhou, Ruizhen Zhao, Li Wang, Fan Zou

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?

    A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say? by Zhiwei Cui, Feiyan Cheng, Lihui Wang, Fan Zou, Rumeng Pan, Yuhan Tian, Xiyuan Zhang, Jing She, Yidan Zhang, Xinyuan Yang

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database

    Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database by Fan Zou, Zhiwei Cui, Siyu Lou, Yingyong Ou, Chengyu Zhu, Chengjie Shu, Junyou Chen, Ruizhen Zhao, Zhu Wu, Li Wang, Zhenyong Chen, Huayu Chen, Yuanbo Lan

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis

    From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis by Zhiwei Cui, Zhen Zhai, De Xie, Lihui Wang, Feiyan Cheng, Siyu Lou, Fan Zou, Rumeng Pan, Shixue Chang, Haoyan Yao, Jing She, Yidan Zhang, Xinyuan Yang

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: